glp-1 muscle loss matters: the effects of medically induced weight on skeletal muscle Who says you have to

Coskun T, Sloop KW, Loghin C et al (2018) LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept

The new trial thus strongly reinforces the benefit of GLP-1 for heart failure with preserved ejection fraction and extends that to people with Type 2 diabetes

As she left the store, they said what the size would be comparable to in America, and I didnt really believe them, said ODonnell

The answer is yes, some lean mass loss can occur during weight loss, but this is largely influenced by nutrition, protein intake, and resistance training rather than the medication itself

Research Square